The introduction of GRHL2 into GBM cells likely promotes partial mesenchymal-to-epithelial (MET) transition and renders these cells sensitive to apoptosis induced by HDACi, potentially in part though disrupting mitosis (Figure 5). This evidence concerns the gene GRHL2 and glioblastoma.